ComplyRx

Immunology & inflammation · Live ClinicalTrials.gov data

Bimekizumab (Bimzelx) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 bimekizumab (Bimzelx) trials on ClinicalTrials.gov by enrolment, 1 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

15

Phase 3 trials

1

Actively recruiting

Dec 2027

Next phase 3 primary completion

9,778

Participants across trials

UCB Biopharma SRL

Lead sponsor by trial count

bimekizumab (16)2 active2016–2029
bimekizumab
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingCompleted
'16
'18
'20
'22
'24
'26
'28
bimekizumab
BE AGILEP2
BE VIVIDP3
BE SUREP3
BE READYP3
BE RADIANTP3
BE BRIGHTP3
BE COMPLETEP3
BE OPTIMALP3
BE MOBILE 2P3
BE VITALP3
BE HEARD IP3
BE HEARD IIP3
BE MOVINGP3
BE HEARD EXTP3
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic ArthritisP3
BeSeenP3

Upcoming readouts

1 ahead · bimekizumab

Select a trial to load its full ClinicalTrials.gov record.

Key bimekizumab trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07219420BeSeen: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant…Phase 3RecruitingDec 2027
NCT04436640BE MOVING: A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects W…Phase 3Active, not recruitingAug 2026
NCT03410992BE READY: A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate t…Phase 3CompletedDec 2018
NCT03370133BE VIVID: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Com…Phase 3CompletedJan 2019
NCT03412747BE SURE: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Se…Phase 3CompletedFeb 2019
NCT03536884BE RADIANT: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in A…Phase 3CompletedSept 2019
NCT03895203BE OPTIMAL: A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active …Phase 3CompletedAug 2021
NCT03928743BE MOBILE 2: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Sp…Phase 3CompletedSept 2021
NCT04242498BE HEARD II: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate t…Phase 3CompletedNov 2021
NCT03896581BE COMPLETE: A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Act…Phase 3CompletedDec 2021
NCT04242446BE HEARD I: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate t…Phase 3CompletedApr 2022
NCT03598790BE BRIGHT: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Se…Phase 3CompletedNov 2023

Track bimekizumab with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track bimekizumab

Related drug pipelines

Compare bimekizumab vs dupilumabCompare bimekizumab vs lebrikizumab

FAQ

How many clinical trials are running for bimekizumab?
ClinicalTrials.gov lists more than 16 phase 2–4 bimekizumab trials. This page tracks the 16 largest by enrolment: 1 phase 2, 15 phase 3, and 0 phase 4 among them, with 1 actively recruiting. Updated daily.
Are there clinical trials for Bimzelx?
Bimzelx is the brand name for bimekizumab, so bimekizumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 bimekizumab trials. This page tracks the 16 largest by enrolment: 1 phase 2, 15 phase 3, and 0 phase 4 among them, with 1 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare bimekizumab against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.